1.Prevalence and Clinical Implications of Occult Hepatitis B Virus Infection.
The Korean Journal of Hepatology 2006;12(2):136-139
No abstract available.
Prevalence
;
Humans
;
Hepatitis B/*diagnosis/epidemiology/immunology
2.Definition, Diagnosis, and Prevalence of Occult Hepatitis B Virus Infection.
The Korean Journal of Gastroenterology 2013;62(3):143-147
Occult HBV infection is characterized by the absence of serum HBsAg with persistence of low level of intrahepatic HBV DNA. Several suggested mechanisms for the origin of occult HBV infection include strong suppression of viral replication and gene expression, mutation in the regulatory regions of HBV genome, formation of immunoglobulin-bound HBsAg, viral interference, and blockage of HBsAg secretion from infected hepatocytes. Standardized assays are not yet available, and sensitive HBV DNA amplification assay is necessary for the diagnosis of cryptic infection. Detection rate of HBV DNA is highest in IgG anti-HBc positive population. However, neither anti-HBc nor anti-HBs can be detected in a significant proportion of infected persons. Occult HBV infection occurs in a number of clinical settings and is highly prevalent in HCV-infected patients as well as in patients with cryptogenic chronic liver disease including hepatocellular carcinoma.
DNA, Viral/analysis
;
Hepatitis B/*diagnosis/*epidemiology/metabolism
;
Hepatitis B Antibodies/blood
;
Hepatitis B Core Antigens/immunology
;
Hepatitis B Surface Antigens/blood
;
Humans
3.The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis.
Min Ju KIM ; Oh Sang KWON ; Nak So CHUNG ; Seo Young LEE ; Hyuk Sang JUNG ; Dong Kyun PARK ; Yang Suh KU ; Yu Kyung KIM ; Yun Soo KIM ; Ju Hyun KIM
The Korean Journal of Hepatology 2008;14(1):67-76
BACKGROUND/AIMS: Alcohol and the hepatitis B virus (HBV) exert synergistic effects in hepatocelluar carcinogenesis. We aimed to elucidate the clinical significance of the antibody to hepatitis B core antigen (anti-HBc) and occult HBV infection on the development of hepatocellular carcinoma (HCC) in patients with alcoholic liver cirrhosis (LC). METHODS: Patients with alcoholic LC alone (n=193) or combined with HCC (n=36), who did not have HBsAg or antibody to hepatitis C virus were enrolled. Clinical data and laboratory data including anti-HBc were investigated at enrollment. The polymerase chain reaction was applied to HBV DNA using sera of patients with HCC or LC after age and sex matching. RESULTS: Patients with HCC were older (60+/-11 years vs. 53+/-10 years, mean+/-SD, P<0.001), more likely to be male (100% vs. 89%, P=0.03), and had a higher positive rate of anti-HBc (91.2% vs. 77.3%, P=0.067), and a higher alcohol intake (739+/-448 kg vs. 603+/-409 kg, P=0.076) than those with LC. Age was the only significant risk factor for HCC revealed by multiple logistic regression analysis (odds ratio, 1.056; P=0.003). The positive rate of anti-HBc and alcohol intake did not differ in age- and sex-matched subjects between the LC (n=32) and HCC (n=31) groups. However, the detection rate of serum HBV DNA was higher in the HCC group (48.4%) than in the LC group (0%, P<0.001). CONCLUSIONS: Anti-HBc positivity is not a risk factor for HCC. However, occult HBV infection may be a risk factor for HCC in patients with alcoholic LC.
Adult
;
Aged
;
Antibodies, Viral/blood
;
Carcinoma, Hepatocellular/diagnosis/epidemiology/*etiology
;
DNA, Viral/analysis
;
Female
;
Hepatitis B/*complications/diagnosis
;
Hepatitis B Core Antigens/*immunology
;
Hepatitis B Surface Antigens/immunology
;
Hepatitis B virus/genetics/immunology/isolation & purification
;
Hepatitis C/complications/diagnosis
;
Humans
;
Liver Cirrhosis, Alcoholic/*complications/diagnosis/epidemiology
;
Liver Neoplasms/diagnosis/epidemiology/*etiology
;
Male
;
Middle Aged
;
Risk Factors
4.Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome.
Hwa Young SONG ; Hyo Keun LEE ; June Sung LEE ; Jong Yeon KIM ; Yun Hyuk YIM ; Tae Jun SONG ; Won Ki BAE ; Nam Hoon KIM ; Kyung Ah KIM
The Korean Journal of Internal Medicine 2012;27(1):47-52
BACKGROUND/AIMS: Many patients are diagnosed with cryptogenic hepatocellular carcinoma (HCC) without metabolic syndrome (MS). We investigated the risk factors for cryptogenic HCC in patients with a low body mass index (BMI) or without MS. METHODS: Thirty-six patients were diagnosed with cryptogenic HCC over a 10-year period at a tertiary research hospital. Data including BMI score and risk factors for MS were analyzed retrospectively. Patients with fewer than two risk factors for MS (n = 16) were compared with those with two or more risk factors (n = 20). Patients with high BMI (> or = 23 kg/m2, n = 20) were also compared with those with lower BMI (n = 16). RESULTS: Patients with fewer than two risk factors for MS were significantly more likely to smoke and be hepatitis B surface antibodies (anti-HBs)-positive vs. patients with two or more risk factors. However, only smoking was statistically significant on multivariate analysis. Peaks of BMI were observed in two regions. Lower BMI was significantly associated with the presence of anti-HBs compared with high BMI, although this association was not statistically significant on multivariate analysis. CONCLUSIONS: Smoking is a potential risk factor for cryptogenic HCC in patients without MS. Remote hepatitis B virus infection may be a risk factor for cryptogenic HCC in patients without MS or with a low BMI.
Aged
;
Aged, 80 and over
;
*Body Mass Index
;
Carcinoma, Hepatocellular/*epidemiology
;
Chi-Square Distribution
;
Female
;
Hepatitis B/diagnosis/epidemiology
;
Hepatitis B Antibodies/blood
;
Hepatitis B Surface Antigens/immunology
;
Humans
;
Liver Neoplasms/*epidemiology
;
Logistic Models
;
Male
;
Metabolic Syndrome X/*epidemiology
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Risk Assessment
;
Risk Factors
;
Smoking/adverse effects/epidemiology
;
Time Factors
5.Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital.
Jae Hoon KIM ; Ju Seung KIM ; Jong Joon LEE ; Jung Ho KIM ; Suk Young KIM ; Young Kul JUNG ; Oh Sang KWON ; Yun Soo KIM ; Duck Joo CHOI ; Ju Hyun KIM
The Korean Journal of Internal Medicine 2014;29(3):307-314
BACKGROUND/AIMS: The Ministry of Health and Welfare and the Korea Centers for Disease Control and Prevention in South Korea have been organizing hepatitis B virus (HBV) vertical infection prevention projects since July 2002. In this single-institute study, the results of surveys conducted in target mothers who delivered babies in a tertiary hospital were investigated and analyzed. METHODS: Of the 9,281 mothers and their 9,824 neonates born between July 2002 and December 2012, 308 hepatitis B surface antigen (HBsAg)-positive mothers and their 319 neonates were selected for this study, and their records were analyzed retrospectively. RESULTS: A total of 308 mothers were HBsAg-positive, with an HBV prevalence of 3.32% (308/9,281). There were 319 neonates born to these HBsAg-positive mothers, and 252 were confirmed to as either HBsAg-positive or -negative. Four were confirmed as HBsAg-positive, with a 1.59% (4/252) HBV vertical infection rate. All the mothers of neonates who had an HBV vertical infection were hepatitis B e antigen (HBeAg)-positive. Among the HBsAg-positive neonates, three were HBeAg-positive and had an HBV DNA titer of 1.0 x 10(8) copies/mL. CONCLUSIONS: The HBV prevalence of mothers was 3.32% (308/9,281), and their vertical infection rate was 1.59% (4/252). Thus, the South Korean HBV vertical infection prevention projects are effective, and, accordingly, HBV prevalence in South Korea is expected to decrease continuously.
Adult
;
Biological Markers/blood
;
DNA, Viral/blood
;
Female
;
Health Surveys
;
Hepatitis B/blood/diagnosis/epidemiology/prevention & control/*transmission/virology
;
Hepatitis B Surface Antigens/blood
;
Hepatitis B e Antigens/blood
;
Hepatitis B virus/genetics/immunology
;
Humans
;
Infant, Newborn
;
*Infectious Disease Transmission, Vertical/prevention & control
;
*National Health Programs
;
Pregnancy
;
Prevalence
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
*Tertiary Care Centers
;
Viral Load
6.Changing seroprevalence of hepatitis B virus markers of adults in Singapore.
Wei Wei HONG ; Li Wei ANG ; Jeffrey L CUTTER ; Lyn JAMES ; Suok Kai CHEW ; Kee Tai GOH
Annals of the Academy of Medicine, Singapore 2010;39(8):591-598
<b>INTRODUCTIONb>We presented the findings from 2 seroprevalence studies conducted 6 years apart, so as to determine changes in the hepatitis B surface antigen (HBsAg) positivity rate and immunity to hepatitis B virus (HBV) among Singapore residents aged 18 to 69 years, and to assess the impact of a 4-year catch-up hepatitis B immunisation programme for adolescents and young adults launched in 2001.
<b>MATERIALS AND METHODSb>Two hepatitis B seroprevalence studies (HBSS) were conducted in 1999 and 2005 based on stored blood samples collected from 4698 participants aged 18 to 69 years during the national health survey (NHS) 1998 and from 3460 participants during the NHS 2004, respectively. Serology for HBsAg, hepatitis B e antigen (HBeAg) and antibody to HBsAg (anti-HBs) were tested by enzyme immunoassay in HBSS 1999 and electrochemiluminescence in HBSS 2005.
<b>RESULTSb>The overall age-standardised prevalence of HBsAg among Singapore residents aged 18 to 69 years decreased significantly from 4.0% in HBSS 1999 to 2.8% in HBSS 2005 (P = 0.002). The age-standardised prevalence of HBsAg in males (4.9% in 1999) and Chinese (4.7% in 1999) both decreased significantly to 2.7% and 2.8%, respectively in 2005. The overall age-standardised population immunity to HBV (anti-HBs >10 mIU/ml) increased from 39.7% in 1999 to 42.1% in 2005 (P = 0.019). In particular, the age-specific prevalence of anti-HBs showed a significant increase among those in the age group of 18 to 29 years from 27.9% in 1999 to 41.7% in 2005 (P <0.001) and among those in the age group of 30 to 39 years from 39.9% in 1999 to 44.7% in 2005 (P = 0.021).
<b>CONCLUSIONb>There was an overall decline in the HBsAg positivity rate as well as an overall increase in population immunity to HBV. Following the 4-year catch-up immunisation programme, there was a significant increase in the immunity to HBV infection in the younger population aged 18 to 29 years.
Adolescent ; Adult ; Age Factors ; Aged ; Biomedical Research ; Confidence Intervals ; Female ; Health Surveys ; Hepatitis B ; blood ; diagnosis ; epidemiology ; immunology ; Hepatitis B Surface Antigens ; immunology ; Hepatitis B Vaccines ; Humans ; Immunization Programs ; Immunoenzyme Techniques ; Male ; Middle Aged ; Population Surveillance ; Risk Factors ; Seroepidemiologic Studies ; Singapore ; epidemiology ; Young Adult
7.Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients.
Jeong Hwan YOO ; Seong Gyu HWANG ; Dong Ho YANG ; Myung Su SON ; Chang Il KWON ; Kwang Hyun KO ; Sung Pyo HONG ; Pil Won PARK ; Kyu Sung RIM
The Korean Journal of Gastroenterology 2013;61(4):209-214
BACKGROUND/AIMS: The prevalence of occult HBV infection depends on the prevalence of HBV infection in the general population. Hemodialysis patients are at increased risk for HBV infection. The aim of this study was to determine the prevalence of occult HBV infection in hemodialysis patients. METHODS: Total of 98 patients undergoing hemodialysis in CHA Bundang Medical Center (Seongnam, Korea) were included. Liver function tests and analysis of HBsAg, anti-HBs, anti-HBc and anti-HCV were performed. HBV DNA testing was conducted by using two specific quantitative methods. RESULTS: HBsAg was detected in 4 of 98 patients (4.1%), and they were excluded. Among 94 patients with HBsAg negative and anti-HCV negative, one (1.1%) patient with the TaqMan PCR test and 3 (3.2%) patients with the COBAS Amplicor HBV test were positive for HBV DNA. One patient was positive in both methods. Two patients were positive for both anti-HBs and anti-HBc and one patient was negative for both anti-HBs and anti-HBc. CONCLUSIONS: The present study showed the prevalence of occult HBV infection in HBsAg negative and anti-HCV negative patients on hemodialysis at our center was 3.2%. Because there is possibility of HBV transmission in HBsAg negative patients on hemodialysis, more attention should be given to prevent HBV transmission.
Adult
;
Aged
;
Aged, 80 and over
;
Antibodies/blood
;
DNA, Viral/analysis
;
Feces/*virology
;
Female
;
Hepatitis B/complications/*epidemiology/transmission
;
Hepatitis B Core Antigens/immunology
;
Hepatitis B virus/genetics/immunology
;
Hepatitis C Antibodies/blood
;
Humans
;
Kidney Failure, Chronic/*complications/diagnosis
;
Male
;
Middle Aged
;
Polymerase Chain Reaction
;
Prevalence
;
Renal Dialysis
;
Risk Factors
8.Hepatitis B virus infection and the risk of coronary atherosclerosis.
Reza GHOTASLOU ; Nasser ASLANABADI ; Morteza GHOJAZADEH
Annals of the Academy of Medicine, Singapore 2008;37(11):913-915
<b>INTRODUCTIONb>Many studies have reported on the association between human coronary artery disease (CAD) and certain persistent bacterial and viral infections. Currently, it is unclear whether hepatitis B virus infection is associated with the risk of the atherosclerosis. The aim of this study was to investigate the possible association between hepatitis B virus infection and angiography-proven CAD.
<b>MATERIALS AND METHODSb>Sera from 5,004 patients who underwent coronary angiography were tested for hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbant assay at Madani Heart Hospital, Tabriz University of Medical Sciences, Iran.
<b>RESULTSb>Our study population comprised 66% male and 34% female, with an age range of 36 to 86 years. The prevalence of HBsAg positivity tended to be higher in CAD patients than in those without CAD (3.28% versus 2.17%), but the difference was not statistically significant.
<b>CONCLUSIONb>Our results suggest that hepatitis B virus infection is not associated with coronary atherosclerosis in this population.
Child, Preschool ; Cholesterol, HDL ; blood ; Cholesterol, LDL ; blood ; Cholesterol, VLDL ; blood ; Coronary Angiography ; Coronary Artery Disease ; diagnosis ; epidemiology ; etiology ; Cross-Sectional Studies ; Enzyme-Linked Immunosorbent Assay ; Female ; Hepatitis B ; blood ; complications ; epidemiology ; Hepatitis B Surface Antigens ; blood ; Hepatitis B virus ; immunology ; Humans ; Incidence ; Infant ; Iran ; epidemiology ; Male ; Retrospective Studies ; Risk Factors ; Sex Distribution
9.Clinical features of acute viral hepatitis B in Korea: a multi-center study.
Hye Jin CHOI ; Soon Young KO ; Won Hyeok CHOE ; Yeon Seok SEO ; Ji Hoon KIM ; Kwan Soo BYUN ; Young Seok KIM ; Seung Up KIM ; Soon Koo BAIK ; Jae Youn CHEONG ; Tae Yeob KIM ; Oh Sang KWON ; Jeong Han KIM ; Chang Hong LEE ; So Young KWON
The Korean Journal of Hepatology 2011;17(4):307-312
BACKGROUND/AIMS: The incidence of Hepatitis B has significantly declined since the introduction of an HBV vaccination program. The aim of this study was to investigate recent clinical features of acute viral hepatitis B (AVH-B) in Korea. METHODS: A total of 2241 patients with acute viral hepatitis were enrolled and their data were collected from nine medical-centers between January 2006 and December 2009. RESULTS: One hundred nineteen (5.3%) of the 2241 were diagnosed as AVH-B. Among 78 patients with AVH-B whose data were analyzed, 50 were male, and the mean age was 38.6 years. In an initial test, mean AST, ALT and total-bilirubin levels were 1296.2 IU/L, 2109.6 IU/L and 9.3 mg/dl, respectively. Positivity frequencies for HBeAg and anti-HBe were 55.1% and 67.9%, respectively, and the mean HBV DNA level was 5.2 log10 copies/ml. The mean length of hospitalization was 11.6 days. During follow-up, AST, ALT and total bilirubin levels were normalized or near-normalized in all patients without serious complications. Sixty-three of 66 (95.4%) patients showed HBsAg loss and 37 (56.1%) patients showed HBsAg seroconversion. Only 3 patients (4.5%) showed persistent hepatitis B viremia. There was no case of death or liver transplantation. Nine patients (11.3%) had received anti-viral agents and their clinical outcomes were not significantly different from those of patients treated without antiviral agents. CONCLUSIONS: The prevalence of AVH-B among acute hepatitis patients is relatively low in Korea. AVH-B infection can be cured without complications in almost all patients, regardless of antiviral treatment.
Acute Disease
;
Adult
;
Alanine Transaminase/blood
;
Antiviral Agents/therapeutic use
;
Aspartate Aminotransferases/blood
;
Bilirubin/blood
;
DNA, Viral/analysis
;
Female
;
Hepatitis B/*diagnosis/drug therapy/epidemiology
;
Hepatitis B Antibodies/blood
;
Hepatitis B e Antigens/blood/immunology
;
Humans
;
Male
;
Middle Aged
;
Retrospective Studies